SpringWorks Therapeutics (SWTX) Reports Q2 Loss, Tops Revenue Estimates
SWTXSpringWorks Therapeutics(SWTX) ZACKS·2024-08-07 20:41

SpringWorks Therapeutics (SWTX) came out with a quarterly loss of 0.54pershareversustheZacksConsensusEstimateofalossof0.54 per share versus the Zacks Consensus Estimate of a loss of 1.12. This compares to loss of 1.25pershareayearago.Thesefiguresareadjustedfornonrecurringitems.Thisquarterlyreportrepresentsanearningssurpriseof51.791.25 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 51.79%. A quarter ago, it was expected that this biopharmaceutical company would post a loss of 1.17 per share when it actually produced a loss of $1.18, delivering a surprise of -0.85%.Over the last four quarter ...